HKEX: 1177 - Sino Biopharmaceutical Limited

Yield per half year: +46.51%
Sector: Healthcare

Share chart Sino Biopharmaceutical Limited


About

Sino Biopharmaceutical Limited, инвестиционная холдинговая компания, работает как научно-исследовательский фармацевтический конгломерат в Китайской Народной Республике. Он работает в трех сегментах: модернизированные китайские лекарства и химические лекарства, инвестиции и другие.

More details
Компания предлагает лекарства от онкологии, включающие таблетки Qingkeshu, капсулы Focus V, инъекции Annike и капсулы Anyue; лекарства от болезней печени, включая инъекции Tianqing ganmei и диспергируемые таблетки Runzhong; и лекарственные средства для респираторной системы, такие как суспензия Tianqingsuchang для ингаляций и Tianyun для инъекций. Он также предоставляет лекарства для хирургии / обезболивания, включая катаплазмы Дебайан и мягкие капсулы Гайсанчунь; и сердечно-сосудистые препараты, в том числе таблетки Yilunping и Kaina. Кроме того, компания занимается долгосрочными инвестициями; и здравоохранение и больничный бизнес. Компания была зарегистрирована в 2000 году и имеет штаб-квартиру в Ван Чай, Гонконг.


Выручка 24.23
EBITDA 6.72
P/E 67.8
P/S 7.57
EV/EBITDA 26.82
Цена ао 3.36
P/BV 4.56
Дивиденд ао 0.12
Див.доход ао 3.73
Сайт https://www.sinobiopharm.com
Число акций ао 18.80122 млрд
Валюта hkd
ISIN KYG8167W1380
IPO date 2000-09-29
Sector Health Care
Industry Pharmaceuticals
Валюта отчета cny
Change price per day: +4.71% (3.61)
Change price per week: -0.2639% (3.79)
Change price per month: +14.55% (3.3)
Change price per 3 month: +30.8% (2.89)
Change price per half year: +46.51% (2.58)
Change price per year: +41.57% (2.67)
Change price per 3 year: -36.36% (5.94)
Change price per 5 year: -77.09% (16.5)
Change price per year to date: +13.86% (3.32)

Underestimation

Title Value Grade
P/S 2.08 7
P/BV 1.43 9
P/E 23.35 6
EV/EBITDA 11.92 7
Total: 8.13

Efficiency

Title Value Grade
ROA, % 3.65 1
ROE, % 7.74 2
Total: 2.33

Dividends

Title Value Grade
Div yield, % 2.76 6.9
DSI 0.7857 7.86
Total: 5.53

Debt

Title Value Grade
Debt/EBITDA 1.94 7
Total: 6.8

Growth impulse

Title Value Grade
Yield Revenue, % 8.11 2
Yield Ebitda, % 4.59 1
Yield EPS, % -26.15 0
Total: 1.4

ETF Share, % Profitability for 1 year, % Dividends, %
Loncar China BioPharma ETF 2.15 16812.5
KraneShares MSCI All China Health Care Index ETF 2.81586 15.893789242757 2.31691
Avantis Emerging Markets Equity ETF 0.10489 18.966432770719 3.60513
Avantis Emerging Markets Value ETF 0.0589 18.155487104041 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.16928 21.031072825561 3.1719
BNY Mellon International Equity ETF 0.02003 15.957035777761 3.33394
SPDR MSCI ACWI ex-US ETF 0.03179 19.518072289157 3.3217
WisdomTree China ex-State-Owned Enterprises Fund 0.37923 10.656566868868 2.29363
Xtrackers MSCI All World ex US Hedged Equity ETF 0.01441 24.793391417519 3.26685
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.05411 20.440591770689 3.04307
Dimensional World ex U.S. Core Equity 2 ETF 0.03443 17.752007136485 3.62488
Dimensional Emerging Markets Core Equity 2 ETF 0.10382 19.47885519009 3.34087
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.09955 21.603755576451 2.84808
Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF 0.10232 22.411453744493 2.86877
Franklin FTSE Asia ex Japan ETF 0.05429 18.172668581388 2.66768
Franklin FTSE China ETF 0.20843 16.86133572926 3.35323
Schwab Fundamental International Small Co. Index ETF 0.03587 13.188542650299 3.46652
Schwab Fundamental Emerging Markets Equity ETF 0.06032 25.298421255295 5.10539
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.13293 24.697077690663 3.47133
Goldman Sachs MarketBeta International Equity ETF 0.02312 15.103837471783 3.36845
SPDR S&P China ETF 0.18912 20.508811824901 3.40103
IQ Candriam International Equity ETF 0.03506 15.257015729285 3.0914
John Hancock Multifactor Emerging Markets ETF 0.02654 17.815078283694 3.42078
KraneShares MSCI All China Index ETF 0.25852 13.635246437443 3.90687
WisdomTree Emerging Markets Efficient Core Fund 0.04881 20.721296331935 3.08497
Nuveen ESG Emerging Markets Equity ETF 0.10825 18.435321456235 2.89278
SPDR MSCI ACWI Climate Paris Aligned ETF 0.01063 30.519031141869 1.86415
Invesco FTSE RAFI Emerging Markets ETF 0.10324 22.090395480226 4.9487
SPDR MSCI Emerging Markets StrategicFactors ETF 0.03714 12.905398778229 3.55491
SPDR Portfolio Emerging Markets ETF 0.06464 23.634735899731 3.1879
SPDR Portfolio MSCI Global Stock Market ETF 0.00414 29.55850326668 2.19607
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.0278 16.494845360825 3.59676
VictoryShares International Value Momentum ETF 0.37635 17.328023171615 4.72459
Vident International Equity Strategy ETF 0.50551 21.923427529626 5.52154
Vanguard ESG International Stock ETF 0.02 17.522299306244 3.07501
iShares MSCI ACWI ETF 0.00842 -18.686547160328 2.10908
First Trust Emerging Markets Small Cap AlphaDEX Fund 0.05316 1072.7278173866 2.70393



Head Job title Payment Year of birth
Ms. Y. Y. Tse Executive Chairwoman of the Board 42.97M 1992 (32 years)
Mr. Eric S. Y. Tse CEO & Executive Director 25.02M 1996 (28 years)
Mr. Ping Tse Founder & Senior Executive Vice Chairman 45.43M 1952 (72 years)
Ms. Cheung Ling Cheng Executive Vice Chairwoman of the Board 38.12M 1964 (60 years)
Mr. Zhoushan Tian Executive Director 2.03M 1964 (60 years)
Mr. Hsin Tse Senior VP & Executive Director 6.53M 1970 (54 years)
Ms. Chun Ling Li Chief Financial Officer N/A 1972 (52 years)
Mr. Song Jin Vice President of Public Affairs, Medicines Policies & ESG 1976 (48 years)
Mr. Sean Chen Chief Strategy Officer 1978 (46 years)
Ms. Chau Ling Yu Assistant VP & Financial Controller 1969 (55 years)

Address: Hong Kong, Wan Chai, Unit 09 Office Tower - open in Google maps, open in Yandex maps
Website: https://www.sinobiopharm.com